PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
0.00%
Gross profit growth of 0.00% while XRF.AX is zero. Bruce Berkowitz would see if minimal improvements could expand further.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.00%
Negative OCF growth while XRF.AX is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
No Data
No Data available this quarter, please select a different quarter.
-76.65%
Negative 10Y revenue/share CAGR while XRF.AX stands at 103.85%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-46.09%
Negative 5Y CAGR while XRF.AX stands at 56.19%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
4.52%
3Y revenue/share CAGR above 1.5x XRF.AX's 0.32%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
125.06%
10Y OCF/share CAGR under 50% of XRF.AX's 2420.70%. Michael Burry would worry about a persistent underperformance in cash creation.
14602.28%
Positive OCF/share growth while XRF.AX is negative. John Neff might see a comparative advantage in operational cash viability.
31.81%
Positive 3Y OCF/share CAGR while XRF.AX is negative. John Neff might see a big short-term edge in operational efficiency.
99.03%
Below 50% of XRF.AX's 279.35%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-1464.60%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
84.00%
Positive short-term CAGR while XRF.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1408.92%
3Y equity/share CAGR above 1.5x XRF.AX's 9.81%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.00%
We cut SG&A while XRF.AX invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.